NCT07173556 2025-09-15A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast CancerQilu Pharmaceutical Co., Ltd.Phase 1/2 Not yet recruiting96 enrolled
NCT07125950 2025-08-15SHR2554 Combined With Endocrine Therapy in Advanced Breast CancerHenan Cancer HospitalPhase 2 Not yet recruiting60 enrolled
NCT07083505 2025-07-24A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2 Not yet recruiting60 enrolled
NCT07041437 2025-06-27Study of SHR-A2102 Combined Other Antitumor Drugs in Advanced Breast CancerFudan UniversityPhase 2 Not yet recruiting48 enrolled